Clinical Trials Browser

Phase 3 × dalpiciclib × 30 days × Clear all

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Phase 3 Recruiting

Breast Neoplasms